IMAX CORP
For the period ended Jun 30, 2025. Filed Jul 24, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 24, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a)None.
(b)None.
(c)Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
On June 11, 2025, Robert D. Lister, the Company’s Chief Legal Officer & Senior Executive Vice President, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K under the Exchange Act (“Item 408”) and such arrangement, the “Plan”) for the sale of up to 70,143 common shares of the Company. This total includes 50,143 previously granted stock options that are due to expire on March 7, 2026. Sales under this Plan may commence on September 15, 2025, after the completion of the required cooling off period under Rule 10b5-1. The Plan will terminate on March 6, 2026, or earlier if all shares under the Plan have been sold. This trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c). No other Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as defined in Item 408) were adopted orterminated by any directors or officers of the Company during the second quarter of 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.